Atractylenolide I-mediated Notch pathway inhibition attenuates gastric cancer stem cell traits

被引:78
作者
Ma, Li [1 ,2 ]
Mao, Rurong [1 ,2 ]
Shen, Ke [1 ,2 ]
Zheng, Yuanhong [1 ,2 ]
Li, Yueqi [1 ,2 ]
Liu, Jianwen [1 ,2 ]
Ni, Lei [3 ]
机构
[1] E China Univ Sci & Technol, Sch Pharm, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China
[2] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Respirat, Shanghai 200025, Peoples R China
关键词
Gastric cancer; Cancer stem cells; Atractylenolide I; Notch; CD44; ATRACTYLODES-MACROCEPHALA; EXPRESSION; JAPONICA; MARKERS; TUMOR; CD44;
D O I
10.1016/j.bbrc.2014.05.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Atractylenolide I (AT-I), one of the main naturally occurring compounds of Rhizome Atractylodis Macrocephalae, has remarkable anti-cancer effects on various cancers. However, its effects on the treatment of gastric cancer remain unclear. Via multiple cellular and molecular approaches, we demonstrated that AT-I could potently inhibit cancer cell proliferation and induce apoptosis through inactivating Notch pathway. AT-I treatment led to the reduction of expressions of Notch1, Jagged1, and its downstream Hes1/ Hey1. Our results showed that AT-I inhibited the self-renewal capacity of gastric stem-like cells (GCSLCs) by suppression of their sphere formation capacity and cell viability. AT-I attenuated gastric cancer stem cell (GCSC) traits partly through inactivating Notch1, leading to reducing the expressions of its downstream target Hes1, Hey1 and CD44 in vitro. Collectively, our results suggest that AT-I might develop as a potential therapeutic drug for the treatment of gastric cancer. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 29 条
[1]
Notch signalling in cancer stem cells [J].
Bolos, Victoria ;
Blanco, Moises ;
Medina, Vanessa ;
Aparicio, Guadalupe ;
Diaz-Prado, Silvia ;
Grande, Enrique .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01) :11-19
[2]
Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes [J].
Deftos, ML ;
Huang, E ;
Ojala, EW ;
Forbush, KA ;
Bevan, MJ .
IMMUNITY, 2000, 13 (01) :73-84
[3]
Notch, a universal arbiter of cell fate decisions [J].
Ehebauer, Matthias ;
Hayward, Penelope ;
Arias, Alfonso Martinez .
SCIENCE, 2006, 314 (5804) :1414-1415
[4]
The Notch target genes Hey1 and Hey2 are required for embryonic vascular development [J].
Fischer, A ;
Schumacher, N ;
Maier, M ;
Sendtner, M ;
Gessler, M .
GENES & DEVELOPMENT, 2004, 18 (08) :901-911
[5]
Huguier M, 2000, ANN CHIR, V125, P89
[6]
Antibacterial Activity of Phytochemicals Isolated from Atractylodes japonica against Methicillin-Resistant Staphylococcus aureus [J].
Jeong, Seung-Il ;
Kim, Seon-Young ;
Kim, Sang-Jun ;
Hwang, Byung-Soon ;
Kwon, Tae-Ho ;
Yu, Kang-Yeol ;
Hang, Seung-Ho ;
Suzuki, Koji ;
Kim, Kang-Ju .
MOLECULES, 2010, 15 (10) :7395-7402
[7]
Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz [J].
Li, Cui-Qin ;
He, Lang-Chong ;
Dong, Hai-Yan ;
Jin, Ju-Qing .
JOURNAL OF ETHNOPHARMACOLOGY, 2007, 114 (02) :212-217
[8]
Notch signaling from tumor cells: A new mechanism of angiogenesis [J].
Li, JL ;
Harris, AL .
CANCER CELL, 2005, 8 (01) :1-3
[9]
Five new eudesmane-type sesquiterpenoid lactones biotransformed from atractylenolide I by rat hepatic microsomes [J].
Li, Ying ;
Yang, Xiu-Wei .
FITOTERAPIA, 2013, 85 :95-100
[10]
B1, a Novel Amonafide Analogue, Overcomes the Resistance Conferred by Bcl-2 in Human Promyelocytic Leukemia HL60 Cells [J].
Liang, Xin ;
Xu, Yufang ;
Xu, Ke ;
Liu, Jianwen ;
Qian, Xuhong .
MOLECULAR CANCER RESEARCH, 2010, 8 (12) :1619-1632